Bibliographic Details
| Title: |
A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis. |
| Authors: |
Ritchie S; San Antonio Military Medical Center, San Antonio, Texas. Electronic address: simonaritchie@hotmail.com., Neal D; San Antonio Military Medical Center, San Antonio, Texas., Shlevin H; Galectin Therapeutics, Norcross, Georgia., Allgood A; Galectin Therapeutics, Norcross, Georgia., Traber P; Galectin Therapeutics, Norcross, Georgia. |
| Source: |
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2017 Oct; Vol. 77 (4), pp. 753-755. |
| Publication Type: |
Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
